Bliss GVS Pharma Limited is a pharmaceutical company engaged in the global manufacturing, marketing, and export of pharmaceutical products, specializing in suppositories and pessaries.

The company holds a robust portfolio of over 250 products and operates five WHO-GMP, EU-GMP compliant facilities, with a significant market presence in Sub-Saharan Africa.

Bliss GVS focuses on research and development, with a dedicated center and a team of over 50 scientists recognized by the Government of India for advancements in formulations.

Despite facing regulatory hurdles in Ghana, the company resolved issues promptly to resume operations and maintain growth momentum.

Significant divestments have been made to streamline focus on core pharmaceutical operations, and a new multi-dosage facility in Maharashtra supports expanded product offerings.